Inclusion Criteria:  18，Advanced uncommon pathological types of lung cancer by histopathology whether or not it is accompanied by a driver mutation Treatment Plan is pembrolizumab 200mg iv q21d  Exclusion Criteria:  - Patients received antitumor treatment before Patients with contraindication of chemotherapy Pregnant or breast feeding women